Literature DB >> 25724309

Influence of Hepatic Inflammation on FibroScan Findings in Diagnosing Fibrosis in Patients with Chronic Hepatitis B.

Xianghua Zeng1, Cheng Xu1, Dengming He2, Huiyan Zhang1, Jie Xia1, Dairong Shi1, Lingjun Kong1, Xiaoqin He1, Yuming Wang3.   

Abstract

Hepatic inflammation may affect the performance of FibroScan. This prospective study investigated the influence of hepatic inflammation on liver stiffness measurement (LSM) values by assessing FibroScan and liver biopsy findings in 325 patients with chronic hepatitis B. Liver fibrosis and inflammation were classified into five stages (S0-S4) and grades (G0-G4) according to the Scheuer scoring system. LSM values were correlated with fibrosis stage and inflammation grade (r = 0.479, p < 0.001, and r = 0.522, p < 0.001, respectively). Although LSM values increased in parallel with inflammation grade, no significant differences were found between patients with significant fibrosis (S2-S4) (p > 0.05). For inflammation grades G0, G1, G2 and G3, areas under receiver operating characteristic curves of FibroScan for significant fibrosis were 0.8267 (p < 0.001), 0.6956 (p < 0.001), 0.709 (p = 0.0012) and 0.6947 (p = 0.137), respectively. Inflammation has a significant influence on LSM values in patients with chronic hepatitis B with mild fibrosis, but not in those with significant fibrosis.
Copyright © 2015 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic hepatitis B; FibroScan; Inflammation; Liver stiffness measurement; Significant liver fibrosis

Mesh:

Year:  2015        PMID: 25724309     DOI: 10.1016/j.ultrasmedbio.2015.01.011

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  11 in total

1.  Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model.

Authors:  An Tang; François Destrempes; Siavash Kazemirad; Julian Garcia-Duitama; Bich N Nguyen; Guy Cloutier
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

2.  Plasma Levels of Homocysteine is Associated with Liver Fibrosis in Health Check-Up Population.

Authors:  Dan Lv; Zepu Wang; Shuai Ji; Xiaoxi Wang; Huiqing Hou
Journal:  Int J Gen Med       Date:  2021-09-03

3.  Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C.

Authors:  Sheng-Hung Chen; Cheng-Yuan Peng; Hsueh-Chou Lai; I-Ping Chang; Chiung-Ju Lee; Wen-Pang Su; Chia-Hsin Lin; Jung-Ta Kao; Po-Heng Chuang
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

4.  Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.

Authors:  Rong-Qi Wang; Qing-Shan Zhang; Su-Xian Zhao; Xue-Min Niu; Jing-Hua Du; Hui-Juan Du; Yue-Min Nan
Journal:  J Int Med Res       Date:  2016-11-11       Impact factor: 1.671

5.  The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years.

Authors:  Jeong-Ju Yoo; Yeon Seok Seo; Young Seok Kim; Soung Won Jeong; Jae Young Jang; Sang Jun Suh; Hyung Joon Yim; Ki Tae Suk; Dong Joon Kim; Kwang-Hyub Han; Seung Up Kim; Bora Lee; Sang Gyune Kim
Journal:  J Clin Med       Date:  2019-11-24       Impact factor: 4.241

6.  The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis.

Authors:  Se Ri Ryu; Jeong-Ju Yoo; Seong Hee Kang; Soung Won Jeong; Moon Young Kim; Young Kyu Cho; Young Chang; Sang Gyune Kim; Jae Young Jang; Young Seok Kim; Soon Koo Baik; Yong Jae Kim; Su Yeon Park; Baigal Baymbajav
Journal:  Clin Mol Hepatol       Date:  2020-12-03

7.  Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease.

Authors:  Xinyu Yang; Xinxia Chang; Shengdi Wu; Xiaoyang Sun; Xiaopeng Zhu; Liu Wang; Yushan Xu; Xiuzhong Yao; Shengxiang Rao; Xiqi Hu; Mingfeng Xia; Hua Bian; Hongmei Yan; Xin Gao
Journal:  Lipids Health Dis       Date:  2021-03-23       Impact factor: 3.876

8.  Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease.

Authors:  François Destrempes; Marc Gesnik; Boris Chayer; Marie-Hélène Roy-Cardinal; Damien Olivié; Jeanne-Marie Giard; Giada Sebastiani; Bich N Nguyen; Guy Cloutier; An Tang
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

9.  The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals.

Authors:  Lisa Townshend-Bulson; Elena Roik; Youssef Barbour; Dana J T Bruden; Chriss E Homan; Hannah G F Espera; Timothy J Stevenson; Annette M Hewitt; Wileina Rhodes; James E Gove; Julia N Plotnik; Mary M Snowball; John McGilvray; Brenna C Simons; Janet M Johnston; Brian J McMahon
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 10.  Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis.

Authors:  Guobao Chen; Bin Xia; Qiang Fu; Xiang Huang; Fuping Wang; Zhongmin Chen; Yonggang Lv
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.